ITGAM and osteosarcoma: Anti-tumorigenic effects have also been reported where the type 2 diabetes drug, metformin was shown to induce anti-tumor effects through the metabolic reprogramming of CD11b+ myeloid cells, causing them to inhibit osteosarcoma tumor growth [40].